Maxidex
Maxidex is a medicine authorised by Swissmedic under authorisation number 30058. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 06 January 1964 and the authorisation is valid without a time limit. ATC code S01BA01 places the medicine in the group Ophthalmologicals.
| Authorisation number | 30058 |
|---|---|
| Name | Maxidex |
| Full name | Maxidex, Augentropfensuspension |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | S01BA01 |
| First authorisation | 06 January 1964 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Maxidex, Augentropfensuspension | A | 06 January 1964 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 11 | 5 | ml | S01BA01 | 11.06.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Maxidex authorised in Switzerland?
Yes. Maxidex is authorised by Swissmedic under authorisation number 30058, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Maxidex have?
Maxidex is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Maxidex?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.